scispace - formally typeset
L

Leonardo Brunetti

Researcher at University of Bari

Publications -  10
Citations -  118

Leonardo Brunetti is an academic researcher from University of Bari. The author has contributed to research in topics: Matrix metalloproteinase & Matrix metalloproteinase inhibitor. The author has an hindex of 5, co-authored 10 publications receiving 46 citations.

Papers
More filters
Journal ArticleDOI

New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation

TL;DR: The development of novel FAAH inhibitors able to directly act as PPAR agonists are discussed and their promising utilization as leads for the discovery of highly effective anti-cancer compounds are discussed.
Journal ArticleDOI

Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases.

TL;DR: A review of the most recent literature regarding the discovery of secondary metabolites through isolation and structural elucidation, as well as the in vitro and/or in vivo evaluation of their biological effects is discussed in this article.
Journal ArticleDOI

Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2-Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil-Like Compounds.

TL;DR: The whole synthesis of PZ1 in the so-called deep eutectic solvents (DESs), which have emerged as an unconventional class of bio-renewable reaction media in green synthesis, is designed and completed.
Journal ArticleDOI

Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents

TL;DR: The significance of zinc (II) chelating agents in past and future medicinal chemistry research is focused on the importance of selectivity in order to revamp the possibility of their use in therapy, often hindered by possible side effects.
Journal ArticleDOI

Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents

TL;DR: In this paper, the authors used tenuazonic acid (TA) as a chemical scaffold to synthesize and evaluate new derivatives (1, 2, 3, 4, 5) of the anti-AD drug donepezil, which achieved activity in the micromolar range towards all selected targets and demonstrated to be potentially orally absorbed.